Further evidence supporting inflammation as an etiological factor in depression, is that patients receiving interferon Alfa (IFN-α) therapy for various types of cancer develop severe depression, INF being an inflammatory mediator [33-35]. Here, CBLIF is linked to depressive symptom measurement.